KVUE.NYSEKenvue INC

Form 4: Kenvue Inc. Executive Jan Meurer Reports Stock Transactions Following RSU Vesting

Sentiment:

SEC Form 4 Filing


Group President of North America at Kenvue Inc., Jan Meurer, reports the vesting of restricted stock units (RSUs) and subsequent stock transactions.

Summary

  • Jan Meurer, Group President, North America at Kenvue Inc., filed a Form 4 detailing changes in beneficial ownership.
  • The report covers transactions on February 13, 2025, and February 14, 2025, involving the vesting of Restricted Stock Units (RSUs) and the subsequent acquisition and disposal of common stock.
  • On February 13, 2025, 2,119 RSUs vested and converted into common stock, and 879 shares were withheld for tax payments at a price of $21.23.
  • On February 14, 2025, 4,630 and 11,572 RSUs vested and converted into common stock, with 1,661 and 4,169 shares respectively withheld for tax payments at a price of $21.75.
  • Following these transactions, Meurer directly owns 28,764.45 shares of Kenvue Inc. common stock and no derivative securities.

Sentiment

Score: 7

Explanation: The document is a routine regulatory filing detailing stock transactions related to RSU vesting, which is a neutral event. The sentiment is slightly positive as it reflects ongoing executive compensation and alignment with company performance.

Industry Context

Form 4 filings are a routine part of the US stock market, providing transparency into the transactions of company insiders. This filing indicates the vesting of previously granted stock awards and subsequent tax-related stock disposals, which is a common occurrence.

Comparison to Industry Standards

  • Executive compensation packages often include restricted stock units (RSUs) that vest over time, aligning executive interests with long-term shareholder value.
  • Tax withholding upon vesting of RSUs is a standard practice across publicly traded companies to cover the executive's income tax obligations.
  • The specific number of RSUs granted and the vesting schedule vary depending on the company's compensation policies and the executive's role and performance.
  • Comparing Meurer's holdings and transactions to those of executives at comparable consumer health companies like Haleon or Perrigo would provide further context.

Stakeholder Impact

  • The transactions have a minor impact on shareholders as they reflect the standard vesting of executive compensation.
  • Employees may view the vesting of RSUs as a positive sign of executive alignment with company goals.

Key Dates

DateDescription
02/13/2024First vesting date of an RSU award in three equal installments.
08/23/2023Date of Kenvue's separation from Johnson & Johnson.
02/13/2025Vesting of 2,119 Restricted Stock Units and tax withholding.
02/14/2025Vesting of 4,630 and 11,572 Restricted Stock Units and tax withholding.
02/13/2026Final vesting date of an RSU award in three equal installments.
02/18/2025Date of Form 4 signature.

Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.